An MRI-defined measure of cerebral lesion severity to assess the therapeutic effect of glatiramer acetate in multiple sclerosis

Authors
Category Primary study
JournalNeurology
Year 2016
This article has no abstract
Epistemonikos ID: e56612c158cb99bacbed2bd953ab36d7246bb0a8
First added on: Feb 07, 2025